Nature Immunology: doi: /ni Supplementary Figure 1. Id2 and Id3 define polyclonal T H 1 and T FH cell subsets.

Similar documents
Nature Immunology: doi: /ni Supplementary Figure 1. Gene expression profile of CD4 + T cells and CTL responses in Bcl6-deficient mice.

Nature Immunology: doi: /ni Supplementary Figure 1. Transcriptional program of the TE and MP CD8 + T cell subsets.

SUPPLEMENTARY INFORMATION. Supp. Fig. 1. Autoimmunity. Tolerance APC APC. T cell. T cell. doi: /nature06253 ICOS ICOS TCR CD28 TCR CD28

Supplementary Figure S1. PTPN2 levels are not altered in proliferating CD8+ T cells. Lymph node (LN) CD8+ T cells from C57BL/6 mice were stained with

Supplementary Figure 1. Efficiency of Mll4 deletion and its effect on T cell populations in the periphery. Nature Immunology: doi: /ni.

Supplementary. presence of the. (c) mrna expression. Error. in naive or

and follicular helper T cells is Egr2-dependent. (a) Diagrammatic representation of the

TGF-β receptor maintains CD4 T helper cell identity during chronic viral infections

Nature Medicine doi: /nm.3957

Nature Immunology: doi: /ni Supplementary Figure 1

Supplemental Figure 1

SUPPLEMENTARY FIGURES

Supplementary Figure 1. mrna expression of chitinase and chitinase-like protein in splenic immune cells. Each splenic immune cell population was

Supplementary Figure 1 IL-27 IL

Tbk1-TKO! DN cells (%)! 15! 10!

The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep

Supplemental Information. Checkpoint Blockade Immunotherapy. Induces Dynamic Changes. in PD-1 CD8 + Tumor-Infiltrating T Cells

Supplementary Figure 1: Expression of NFAT proteins in Nfat2-deleted B cells (a+b) Protein expression of NFAT2 (a) and NFAT1 (b) in isolated splenic

MATERIALS AND METHODS. Neutralizing antibodies specific to mouse Dll1, Dll4, J1 and J2 were prepared as described. 1,2 All

Eosinophils are required. for the maintenance of plasma cells in the bone marrow

CD44

In Vivo RNA Interference Screens Identify Regulators of Antiviral CD4 + and CD8 + T Cell Differentiation

Supplemental Figure 1. Activated splenocytes upregulate Serpina3g and Serpina3f expression.

B220 CD4 CD8. Figure 1. Confocal Image of Sensitized HLN. Representative image of a sensitized HLN

Supplementary Figure 1. Characterization of basophils after reconstitution of SCID mice

SUPPLEMENTARY FIGURES

CD80 and PD-L2 define functionally distinct memory B cell subsets that are. Griselda V Zuccarino-Catania, Saheli Sadanand, Florian J Weisel, Mary M

TEB. Id4 p63 DAPI Merge. Id4 CK8 DAPI Merge

CD4 + T cells recovered in Rag2 / recipient ( 10 5 ) Heart Lung Pancreas

% of live splenocytes. STAT5 deletion. (open shapes) % ROSA + % floxed

Supplementary Figure 1. Deletion of Smad3 prevents B16F10 melanoma invasion and metastasis in a mouse s.c. tumor model.

LPS CD40 + IL-4. Vorinostat (24 Hours) Vorinostat (24 Hours) Panobinostat (24 Hours) Panobinostat (24 Hours) Romidepsin (48 Hours)

Supplementary Figure 1. Generation of knockin mice expressing L-selectinN138G. (a) Schematics of the Sellg allele (top), the targeting vector, the

Supplementary Information:

Supporting Information Table of Contents

Supplementary Figure 1

Spleen. mlns. E Spleen 4.1. mlns. Spleen. mlns. Mock 17. Mock CD8 HIV-1 CD38 HLA-DR. Ki67. Spleen. Spleen. mlns. Cheng et al. Fig.

Generation of ST2-GFP reporter mice and characterization of ILC1 cells following infection

Supplementary Information

NK1.1 þ CD8 þ T cells escape TGF-b control and contribute to early microbial pathogen response

Nature Immunology: doi: /ni Supplementary Figure 1. RNA-Seq analysis of CD8 + TILs and N-TILs.

Nature Immunology: doi: /ni Supplementary Figure 1. Huwe1 has high expression in HSCs and is necessary for quiescence.

Blocking antibodies and peptides. Rat anti-mouse PD-1 (29F.1A12, rat IgG2a, k), PD-

X P. Supplementary Figure 1. Nature Medicine: doi: /nm Nilotinib LSK LT-HSC. Cytoplasm. Cytoplasm. Nucleus. Nucleus

Akt and mtor pathways differentially regulate the development of natural and inducible. T H 17 cells

well for 2 h at rt. Each dot represents an individual mouse and bar is the mean ±

Supplemental Figure 1. Protein L

HD1 (FLU) HD2 (EBV) HD2 (FLU)

Supplementary Figures

Therapeutic PD L1 and LAG 3 blockade rapidly clears established blood stage Plasmodium infection

SUPPLEMENTARY INFORMATION

ECM1 controls T H 2 cell egress from lymph nodes through re-expression of S1P 1

Pathologic Stage. Lymph node Stage

Transcription factor Foxp3 and its protein partners form a complex regulatory network

Supplementary Figures

Supplementary Figures

activation with anti-cd3/cd28 beads and 3d following transduction. Supplemental Figure 2 shows

IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia

Quantitative PPARγ expression affects the balance between tolerance and immunity

Krishnamoorthy et al.,

Supporting Online Material for

Nature Immunology: doi: /ni Supplementary Figure 1. Cytokine pattern in skin in response to urushiol.

EPIGENETIC RE-EXPRESSION OF HIF-2α SUPPRESSES SOFT TISSUE SARCOMA GROWTH

IMMUNOLOGICAL MEMORY. CD4 T Follicular Helper Cells. Memory CD8 T Cell Differentiation

The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23- induced production of the cytokine GM-CSF

Supplementary Figure 1 Cytokine receptors on developing thymocytes that can potentially signal Runx3d expression.

Supplementary Figure 1) GABAergic enhancement by leptin hyperpolarizes POMC neurons A) Representative recording samples showing the membrane

Supplemental Information. Genomic Characterization of Murine. Monocytes Reveals C/EBPb Transcription. Factor Dependence of Ly6C Cells

Peli1 negatively regulates T-cell activation and prevents autoimmunity

doi: /nature14508 Rappsilber et al.

Mouse Clec9a ORF sequence

Supplementary Fig. 1 p38 MAPK negatively regulates DC differentiation. (a) Western blot analysis of p38 isoform expression in BM cells, immature DCs

Supplementary Figure 1 Chemokine and chemokine receptor expression during muscle regeneration (a) Analysis of CR3CR1 mrna expression by real time-pcr

Supplementary Materials for

Supplementary Figures

Nature Genetics: doi: /ng Supplementary Figure 1

Supplementary Figure 1

Supplemental Figures Supplemental Figure 1:

Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors

LETTER. Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development

Supplemental Information. CD4 + CD25 + Foxp3 + Regulatory T Cells Promote. Th17 Cells In Vitro and Enhance Host Resistance

Nature Immunology: doi: /ni Supplementary Figure 1. Characteristics of SEs in T reg and T conv cells.

Supplementary Figure 1. BMS enhances human T cell activation in vitro in a

Peer review correspondence

Supplemental Table S1

Nature Immunology: doi: /ni Supplementary Figure 1. DNA-methylation machinery is essential for silencing of Cd4 in cytotoxic T cells.

Supplementary Data Table of Contents:

Figure S1. Reduction in glomerular mir-146a levels correlate with progression to higher albuminuria in diabetic patients.

SUPPLEMENTARY INFORMATION

Supplementary Figure 1

Supplementary Figure S1. Flow cytometric analysis of the expression of Thy1 in NH cells. Flow cytometric analysis of the expression of T1/ST2 and

Supplementary information. The proton-sensing G protein-coupled receptor T-cell death-associated gene 8

Supplemental Figure 1. Western blot analysis indicated that MIF was detected in the fractions of

Supplementary Figure 1: STAT3 suppresses Kras-induced lung tumorigenesis

Dendritic cell subsets and CD4 T cell immunity in Melanoma. Ben Wylie 1 st year PhD Candidate

Supplementary Figure 1 Lymphocytes can be tracked for at least 4 weeks after

Cell isolation. Spleen and lymph nodes (axillary, inguinal) were removed from mice

Supplementary Figure 1. Normal T lymphocyte populations in Dapk -/- mice. (a) Normal thymic development in Dapk -/- mice. Thymocytes from WT and Dapk

Bezzi et al., Supplementary Figure 1 *** Nature Medicine: doi: /nm Pten pc-/- ;Zbtb7a pc-/- Pten pc-/- ;Pml pc-/- Pten pc-/- ;Trp53 pc-/-

USP15 stabilizes MDM2 to mediate cancer cell survival and inhibit antitumor T cell responses

Transcription:

Supplementary Figure 1 Id2 and Id3 define polyclonal T H 1 and T FH cell subsets. Id2 YFP/+ (a) or Id3 GFP/+ (b) mice were analyzed 7 days after LCMV infection. T H 1 (SLAM + CXCR5 or CXCR5 PD-1 ), T FH (SLAM lo CXCR5 + or CXCR5 + PD-1 ) or GC T FH (CXCR5 + PD-1 + ) differentiation for the indicated antigen-experienced (CD49d + CD11a + ) CD4 + T cell populations was analyzed by flow cytometry and quantified. *p<0.01, **p<0.001 and ***p<0.0001 (two-tailed unpaired Student's t test). Data are representative of three experiments (a,b), each with n = 3 mice per group (mean ± s.e.m.).

Supplementary Figure 2 Knockdown of Id2 results in increased T FH differentiation. SMARTA CD4 + T cells transduced with the indicated shrnamir-rv were transferred into B6 SMARTA CD4 + T cells were transduced with the indicated shrnamir-rv. (a) RNA was isolated from shrnamir-rv + CD4 + T cells and Id2 expression was determined by qrt- PCR. shrnamir-rv + CD4 + T cells were transferred into B6 mice and analyzed 6 (b-e) or 3 (f-i) days after LCMV infection. (b,f) Quantitation of shrna + SMARTA CD4 + T cells. (c-e) GC T FH (CXCR5 + PSGL-1 ) cell development was analyzed by flow cytometry (c) and quantified as a fraction of SMARTA CD4 + T cells (d) or total splenocytes (e). (g-i) T FH (CXCR5 + CD25 ) and T H 1 (CD25 + CXCR5 ) differentiation was analyzed by flow cytometry (g) and quantified as a fraction of SMARTA CD4 + T cells (h) or total splenocytes (i). (j,k) OT-II CD4 + T cells transduced with the indicated shrnamir-rv were transferred into B6 mice and analyzed 11 days after footpad immunization with NP-OVA in alum. (j) T FH (CXCR5 + PD-1 + ) and (k) GC T FH (CXCR5 + Bcl6 + ) differentiation was analyzed by flow cytometry and quantified as a fraction of OT-II CD4 + T cells or total lymph node cells. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 (twotailed unpaired Student's t test). Data are pooled from two (a) experiments or representative of two (j,k), four (b-e) or five (f-i) independent experiments with n=6-14 mice per group (mean ± s.e.m.).

Supplementary Figure 3 Expression of Id proteins orchestrates CD4 + T cell differentiation. (a-c) Id2 +/+ CD4-Cre + (Id2 +/+ ) or Id2 fl/fl CD4-Cre + (Id2 / ) SMARTA CD4 + T cells were transferred into B6 mice and analyzed 4 (a) and 7 (a-c) days after LCMV infection. (a) Flow cytometric analysis of CXCR5 and SLAM expression quantified as gmfi on days 4 and 7. (b) Flow cytometric analysis of granzyme B and TCF1 expression (left panels), quantification as a frequency of SMARTA CD4 + T cells

(right panels). (c) Flow cytometric analysis of IFN- and T-bet expression in total SMARTA CD4 + T cells. gmfi of T-bet expression and total number of IFN-y + SMARTA CD4 + T cells is shown. (d) Id2 +/+ CD4-Cre + and Id2 fl/fl CD4-Cre + mice were analyzed 7 days after LCMV infection, SLAM hi CXCR5, SLAM mid CXCR5 mid and SLAM lo CXCR5 + cells were analyzed by flow cytometry (left panels) and quantified as a frequency of antigen-experienced (CD49d + CD11a + ) CD4 + T cells (middle panel) or as total splenic numbers (right panel). (e) SMARTA CD4 + T cells transduced with the indicated shrnamir-rv were transferred into B6 mice and analyzed 3 days after LCMV infection. Quantitation of Bcl6 expression in SMARTA T H 1 (CXCR5 PD-1 ) and T FH (CXCR5 + PD-1 + ) cells is shown. (f) Id2 +/+ CD4-Cre + or Id2 fl/fl CD4-Cre + SMARTA CD4 + T cells were transferred into Bcl6 fl/fl CD4-Cre + mice and analyzed 8 days after LCMV infection. SLAM hi CXCR5, SLAM mid CXCR5 mid and SLAM lo CXCR5 + cells were analyzed by flow cytometry (left panels) and quantified as a frequency of SMARTA CD4 + T cells (middle panel) or as total numbers (right panel) *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 (two-tailed unpaired Student's t test). Data are representative of one (e) or three (a-d,f) independent experiments with n=3-10 mice per group (mean ± s.e.m.).

Supplementary Figure 4 Expression of Id3 limits unregulated differentiation of T FH cells and GC T FH cells. (a) Id3 +/+ CD4-Cre + (Id3 +/+ ) or Id3 fl/fl CD4-Cre + (Id3 / ) SMARTA CD4 + T cells were transferred into B6 mice and analyzed 7 days after LCMV infection. (a) Flow cytometric analysis of CXCR5 + Bcl6 hi (top), SLAM hi CXCR5 (T H 1) and SLAM lo CXCR5 + (T FH ) (middle); or PD-1 CXCR5 (T H 1), PD-1 CXCR5 + (T FH ) and PD-1 + CXCR5 + (GC T FH ) (bottom) populations and quantification as a frequency of SMARTA CD4 + T cells (right panels). (b) Id3 +/+ CD4-Cre + and Id3 fl/fl CD4-Cre + mice were analyzed 7 days after LCMV and PD-1 CXCR5 (T H 1), PD-1 CXCR5 + (T FH ) and PD-1 + CXCR5 + (GC T FH ) expression was analyzed by flow cytometry (left) and quantified as a frequency of antigen-specific (gp66-77) CD4 + T cells (right). (c-d) NIP CD4 + T cells transduced with the indicated RV were transferred into B6 mice and analyzed 6 days (c) or 3 days (d) after LCMV infection. (c) T FH (CXCR5 + SLAM lo ) differentiation was analyzed by flow cytometry and quantified as a frequency of NIP CD4 + T cells. (d) Early T FH (CXCR5 + Bcl6 + ) differentiation was analyzed by flow cytometry and quantified as a frequency of NIP CD4 + T cells. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 (two-tailed unpaired Student's t test). Data are pooled from two (c,d) experiments or representative of two (a,b) independent experiments with n=8-10 mice per group (mean ± s.e.m.).

Supplementary Figure 5 E proteins drive CXCR5 expression and inhibit the formation of T H 1 cells. (a) Id2 +/+ CD4-Cre + or Id2 fl/fl CD4-Cre + SMARTA CD4 + T cells were transduced with the indicated shrnamir-rv and expanded in vitro for 4 days. Graph indicates relative mrna expression of Tcf3 by dsred + SMARTA CD4 + T cells. (b) Gene expression of E proteins and related genes of interest in T H 1 and T FH SMARTA at day 3 after acute LCMV infection measured by RNA-Seq. Cd8a and Cd19 are included as negative controls. Data are from ref. 32 (GSE67336). SMARTA (c) or NIP (d-k) CD4 + T cells transduced with the indicated RV were transferred into B6 mice and analyzed 3 days (c-f) or 6 days (g-k) after LCMV infection. (c) CXCR5 expression by SMARTA T H 1 (CXCR5 Bcl6 ) and T FH (CXCR5 + Bcl6 + ) cells. (d,g) Quantitation of RV + NIP CD4 + T cells. (e) CXCR5 expression by NIP T H 1 (CXCR5 Bcl6 ) and T FH (CXCR5 + Bcl6 + ) cells. (f) Quantitation of Tbet expression by NIP T H 1 (CD25 + CXCR5 ) and T FH (CXCR5 + CD25 ) cells. (h-j) T FH (CXCR5 + SLAM lo ) and T H 1 (SLAM + CXCR5 ) differentiation was analyzed by flow cytometry (h) and quantified as a fraction of NIP CD4 + T cells (i) or total splenocytes (j). (k) CXCR5 expression by NIP T H 1 (SLAM + CXCR5 ) and T FH (CXCR5 + SLAM lo ) cells.. **p<0.01, ***p<0.0001 (two-tailed unpaired Student's t test). Data are pooled from two (i,j) experiments or are representative of two (a,c) or three (d-h,k) independent experiments with n=8-10 mice per group (mean ± s.e.m.).

Supplementary Figure 6 Bcl6 inhibits Id2 expression. (a) Bcl6 fl/fl CD4-Cre + SMARTA CD4 + T cells transduced with the indicated vectors were transferred into B6 mice. (b) WT, Bcl6 fl/wt CD4- Cre + (Bcl6 +/ ), Bcl6 fl/fl CD4-Cre + (Bcl6 / ) SMARTA CD4 + T cells were transferred into B6 mice. Gates used to sort IL-2R + and IL-2R SMARTA CD4 + T cells 3 days after LCMV infection are indicated. (c) Sequences of the primers used in the study. (d) Model for the role of Id and E proteins in orchestrating CD4 + T cell differentiation. Data are representative of 2 independent experiments.